(Q46302136)
Statements
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study (English)
Alejandro Martín
Eulogio Conde
Montserrat Arnan
Miguel A Canales
Guillermo Deben
Rafael Andreu
Pedro García-Sanchez
Lourdes Vázquez
Sara Nistal
María-José Requena
Eva M Donato
José A González
Angel León
Concepción Ruiz
Carlos Grande
María-Dolores Caballero
Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group)
22 October 2008